CPSF7 Antikörper (C-Term)
Kurzübersicht für CPSF7 Antikörper (C-Term) (ABIN629876)
Target
Alle CPSF7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- FLJ12529 antibody was raised against the C terminal of FLJ12529
-
Aufreinigung
- Purified
-
Immunogen
- FLJ12529 antibody was raised using the C terminal of FLJ12529 corresponding to a region with amino acids GASGSSSRKRHRSRERSPSRSRESSRRHRDLLHNEDRHDDYFQERNREHE
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
FLJ12529 Blocking Peptide, (ABIN938558), is also available for use as a blocking control in assays to test for specificity of this FLJ12529 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FLJ12529 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CPSF7 (Cleavage and Polyadenylation Specific Factor 7, 59kDa (CPSF7))
-
Andere Bezeichnung
- FLJ12529
-
Hintergrund
- FLJ12529 is a probable component of the cleavage factor Im complex (CFIm) that plays a key role in pre-mRNA 3' processing.
-
Molekulargewicht
- 52 kDa (MW of target protein)
Target
-